UniSa - IRIS Institutional Research Information System

TRIGGIANI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.711
NA - Nord America 9.874
EU - Europa 2.354
SA - Sud America 940
AF - Africa 85
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 23.985
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.766
HK - Hong Kong 6.781
SG - Singapore 1.808
CN - Cina 856
BR - Brasile 756
VN - Vietnam 569
IT - Italia 506
UA - Ucraina 503
RU - Federazione Russa 350
DE - Germania 310
TR - Turchia 243
IE - Irlanda 211
KR - Corea 187
FI - Finlandia 122
AR - Argentina 93
SE - Svezia 86
GB - Regno Unito 82
IN - India 52
CA - Canada 50
AT - Austria 34
BD - Bangladesh 33
IQ - Iraq 33
MX - Messico 32
EC - Ecuador 30
ES - Italia 29
ID - Indonesia 26
PL - Polonia 25
ZA - Sudafrica 24
JP - Giappone 23
NL - Olanda 17
CO - Colombia 15
FR - Francia 14
PK - Pakistan 13
AE - Emirati Arabi Uniti 12
MA - Marocco 11
PY - Paraguay 11
CZ - Repubblica Ceca 10
JO - Giordania 10
NZ - Nuova Zelanda 10
PE - Perù 10
VE - Venezuela 9
LT - Lituania 8
CH - Svizzera 7
CL - Cile 7
EG - Egitto 7
IL - Israele 7
KE - Kenya 7
UZ - Uzbekistan 7
AU - Australia 6
CR - Costa Rica 6
MY - Malesia 6
UY - Uruguay 5
AM - Armenia 4
CI - Costa d'Avorio 4
DZ - Algeria 4
EU - Europa 4
GR - Grecia 4
KZ - Kazakistan 4
MD - Moldavia 4
PA - Panama 4
PS - Palestinian Territory 4
PT - Portogallo 4
SA - Arabia Saudita 4
AL - Albania 3
AZ - Azerbaigian 3
BE - Belgio 3
BO - Bolivia 3
ET - Etiopia 3
GN - Guinea 3
HN - Honduras 3
HU - Ungheria 3
MK - Macedonia 3
NI - Nicaragua 3
NP - Nepal 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BZ - Belize 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
NG - Nigeria 2
OM - Oman 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
ZM - Zambia 2
AF - Afghanistan, Repubblica islamica di 1
BJ - Benin 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
Totale 23.961
Salva come PNG Salva come JPEG
Città #
Hong Kong 6.781
Ann Arbor 2.093
Woodbridge 1.132
Singapore 851
Chandler 699
Jacksonville 662
Princeton 627
Houston 543
Dallas 525
Ashburn 473
San Jose 431
Wilmington 392
Dong Ket 326
Izmir 223
Dublin 207
Beijing 148
Andover 147
The Dalles 145
Nanjing 133
Boardman 116
Moscow 104
Pellezzano 103
Ho Chi Minh City 89
Los Angeles 84
Munich 79
New York 68
Naples 62
São Paulo 60
Nuremberg 57
Salerno 55
Washington 55
Düsseldorf 50
Shenyang 49
Changsha 45
Fairfield 45
Hebei 42
Columbus 41
Hanoi 40
Norwalk 39
Jiaxing 38
Nanchang 37
Redwood City 37
Buenos Aires 35
Council Bluffs 27
Dearborn 27
Rio de Janeiro 26
Santa Clara 25
Tianjin 25
Rome 23
Lappeenranta 22
Montreal 22
Turku 22
Warsaw 22
Brooklyn 21
Seattle 20
Tokyo 20
Boston 19
Chicago 19
Poplar 19
London 18
Mestre 18
Milan 16
Belo Horizonte 15
Haiphong 15
Pune 15
Vienna 15
Denver 14
Orem 14
Phoenix 14
Seoul 14
Baghdad 13
Curitiba 13
Quito 13
Stockholm 13
Johannesburg 12
Atlanta 11
Cambridge 11
Chennai 11
Da Nang 11
Amman 10
Brasília 10
Charlotte 10
Dhaka 10
Latina 10
Mexico City 10
Raleigh 10
Amsterdam 9
Asunción 9
Falls Church 9
Jinan 9
Biên Hòa 8
Brno 8
Guangzhou 8
Guayaquil 8
New Delhi 8
Salvador 8
San Diego 8
San Francisco 8
Shanghai 8
Volta Redonda 8
Totale 18.789
Salva come PNG Salva come JPEG
Nome #
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project) 942
La triptasi sierica nella diagnosi di mastocitosi sistemica in pazienti adulti senza lesioni cutanee 634
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control 555
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 539
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice 510
Fragments of truth: T-cell targets of polyclonal immunoglobulins in autoimmune diseases 477
Triggers and prodromal symptoms of angioedema attacks in patients with hereditary angioedema 376
Control of arachidonate levels within inflammatory cells. 365
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 340
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 337
Anaphylaxis and cardiovascular diseases 312
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 296
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT 266
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 264
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis 261
Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis 218
Multidisciplinary challenges inmastocytosis and how to address with personalizedmedicine approaches 215
Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology 201
Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils. 200
A review of hereditary angioedema and recombinant human C1-inhibitor treatment 195
Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: The Italian experience 191
A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema 187
Heterogeneity of human Fc epsilon RI-bearing cells. 186
Antigen-induced generation of lyso-phospholipids in human airways. 168
Secretory phospholipases A2 activate selective functions in human eosinophils 164
Allergia alimentare e probiotici: nuovi aspetti sulle interazioni tra il sistema immunitario ed i batteri commensali intestinali 162
Stress and Psychological Factors in the Variable Clinical Phenotype of Hereditary Angioedema in Children: A Pilot Study 159
Arachidonic acid metabolism during antigen and ionophore activation of the mouse bone marrow derived mast cell. 156
Activation of human basophils by staphylococcal protein A. I. The role of cyclic AMP, arachidonic acid metabolites, microtubules and microfilaments. 153
Activation of human inflammatory cells by secreted phospholipases A2 146
Current concepts on diagnosis and treatment of mastocytosis. 143
Molecular and cellular biology of mast cells and basophils. 140
Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor 140
Antileucotrieni nell'asma bronchiale: bilancio e prospettive 136
Advances in the classification and treatment of mastocytosis: Current status and outlook toward the future 136
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 131
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 128
Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases 128
Editorial overview: Immunomodulation: Modulation of the immune system: Per aspera ad astra 126
A unique case of angioedema with anti-C1 inhibitor antibodies and normal C1 inhibitor levels 126
Non lymphomatous clonal B-Cell populations in enlarged lymph nodes in acquired immunodeficiency syndrome. 125
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 124
Biochemical functions of a pool of arachidonic acid associated with triglycerides in human inflammatory cells. 121
Assay of antibody to group A streptococcal carbohydrate by enzyme-linked immunosorbent assay. 120
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group 120
L'acido ialuronico nella regolazione delle risposte infiammatorie ed immunologiche 119
Human Macrophages and Monocytes Express Functional Na+/Ca2+ Exchangers 1 and 3Sodium Calcium Exchange: A Growing Spectrum of Pathophysiological Implications 119
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC 119
Pharmacological modulation of human mast cells and basophils 117
Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. 114
Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils 114
A Survey of Clinical Features of Allergic Rhinitis in Adults 113
Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study 113
Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema 112
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal 111
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions 109
Molecular diagnosis and the Italian Board for ISAC. 108
Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema 108
Are mast cells MASTers in HIV-1 infection? 107
Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. 106
Research needs in allergy: an EAACI position paper, in collaboration with EFA 106
360 degree perspective on allergic rhinitis management in Italy: A survey of GPs, pharmacists and patients 105
Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. 103
Biomarkers for evaluation of mast cell and basophil activation 103
Arachidonic acid remodeling in human inflammatory cells migrating to the lung in vivo. 103
Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. 102
What we should learn from the London Olympics 102
Expression and function of angiopoietins and their tie receptors in human basophils and mast cells 102
Evaluation of vaccination safety in children with mastocytosis 102
Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. 100
Perioperative anaphylactic risk score for risk-oriented premedication. 100
Sensitization to Common and Uncommon Pets or Other Furry Animals: Which May Be Common Mechanisms? 100
Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation. 99
Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. 98
Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor. 98
Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell. 98
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives 98
Mast cells as effector cells of innate immunity and regulators of adaptive immunity 98
Role of human FcεRI+ cells in HIV-1 infection 98
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement 98
Role of human mast cells and basophils in bronchial asthma. 97
HIV-1 envelope gp41 peptides promote migration of human FcεRI+ cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors 97
Phenotypical and functional heterogeneity of human lung macrophages 96
Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis 96
Component resolved diagnosis (CRD): how much is it presently used by Italian allergists? 95
Mutational Spectrum of the C1 Inhibitor Gene in a Cohort of Italian Patients with Hereditary Angioedema: Description of Nine Novel Mutations 94
Management of chronic spontaneous urticaria: practical parameters 94
Mastocytosis presenting as cardiac emergency 94
Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18). 93
Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol. 93
Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage. 93
Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. 93
Studi tossicologici sugli effetti dell'idrochinone e del benzochinone sui basofili umani 93
Simplexide Induces CD1d-Dependent Cytokine and Chemokine Production from Human Monocytes 92
Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study. 92
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. 92
Oxidative stress markers are increased in patients with mastocytosis 91
Recent advances in our understanding of the biochemical interactions between platelet-activating factor and arachidonic acid. 91
Metabolism of platelet-activating factor in the guinea-pig heart. 91
Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. 91
Totale 16.689
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.046
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021726 0 0 0 0 0 0 150 22 91 11 99 353
2021/20221.047 9 3 4 18 10 19 9 44 166 139 137 489
2022/20231.740 184 104 59 200 244 388 12 165 260 6 93 25
2023/20241.002 82 110 122 49 97 174 23 44 11 40 47 203
2024/20252.428 79 34 33 96 109 283 353 246 465 199 281 250
2025/202610.894 1.342 3.676 3.071 568 1.025 558 654 0 0 0 0 0
Totale 24.292